Summary
Latest filing:
Josh Wolfe files SEC Form 4 reports at Eikon Therapeutics, Inc. (EIKN). 1 SEC Form 4 filing on record, dated 6 February 2026. Most recent open-market trade: bought $2.50M of EIKN on 6 February 2026. Lifetime open-market purchases: $5.00M.
Recent Transactions
5Every recent SEC Form 4 transaction Josh Wolfe has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Josh Wolfe files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Column Group IV GP, LP - $39.15M of EIKN open-market activity in the last 12 months
- Lux Venture Partners V, LLC - $5.00M of EIKN open-market activity in the last 12 months
- Kenneth C. Frazier - $2.00M of EIKN open-market activity in the last 12 months
- Foresite Capital Management IV, LLC - $1000K of EIKN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Josh Wolfe?
Josh Wolfe is a corporate insider of Eikon Therapeutics, Inc. (EIKN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Josh Wolfe last file a Form 4?
The only primary Form 4 on record is dated 6 February 2026.
Has Josh Wolfe been buying or selling stock?
Recorded transactions: 2 open-market purchases ($5.00M) and 0 open-market sales across all tracked filings.
Where can I see all of Josh Wolfe's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Josh Wolfe and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
